Publication & Citation Trends
Publications
32 total
A <i>let-7</i> microRNA-Binding Site Polymorphism in <i>KRAS</i> Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy PDF
Cited by 59
OpenAlex
FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study
Cited by 27
OpenAlex
Treated with Salvage Cetuximab / Panitumumab Monotherapy Improved Outcome in Patients with Metastatic Colorectal Cancer Predicts KRAS microRNA-Binding Site Polymorphism in let-7 A Updated
Cited by 0
Semantic Scholar
Effect of EGFR inhibition on HER3/PI3K activation by feedback induction of ErbB heterodimers in cetuximab-sensitive colon cancer cells.
Cited by 0
Semantic Scholar
P1.28 Dusp4 Expression as A Marker of Heterogeneous Signaling in Colorectal Cancer Patients OA
Cited by 10
Semantic Scholar
Clinical Biomarkers in Oncology Focus on Colorectal Cancer
Cited by 26
Semantic Scholar
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Cited by 2,133
OpenAlex
Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients PDF
Cited by 67
OpenAlex
Reply to C. Cremolini et al OA
Cited by 0
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(32)
Lung Cancer Treatments and Mutations
(11)
Hepatocellular Carcinoma Treatment and Prognosis
(10)
Cancer Genomics and Diagnostics
(8)
Cancer Immunotherapy and Biomarkers
(7)
Affiliations
Merck (Germany)
Universitair Ziekenhuis Leuven
Ghent University
Center for Human Genetics
KU Leuven